Printer Friendly
The Free Library
4,474,257 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

FDA warns Los Angeles-area obesity doctor over informed consent violations


A Los Angeles-area doctor who lent his name to a type of stomach-shrinking surgery failed to obtain the full informed consent of 175 patients implanted with an experimental medical device, according to a federal warning letter released Tuesday.

Dr. Mathias A.L. Fobi also implanted 185 patients with an experimental device before receiving approval to do so from either the Food and Drug Administration or the institutional review board overseeing the study, amid other violations of federal regulations, according to the Jan. 24 letter. The FDA posted a largely blacked-out copy of the letter to its Web site on Tuesday.

The copy did not make clear if the same device was used in all the patients.

Fobi, of the Center for Surgical Treatment of Obesity in Hawaiian Gardens, Calif., invented the Fobi pouch. This type of gastric bypass surgically reduces the size of the stomach to a one- or two-tablespoon pocket, vastly restricting the amount patients can eat. It's been credited with helping obese patients shed hundreds of pounds.

It wasn't clear from the redacted letter what sort of medical device or devices Fobi was studying. However, the Fobi pouch surgery includes the placing of a band around the stomach pouch's opening to limit stretching over time that can allow patients to eat more.

Fobi was performing an operation late Tuesday and wasn't available for comment. The FDA gave him 15 working days to reply to the warning letter.

The FDA inspected Fobi's clinic Sept. 19-29, according to the five-page letter, signed by Timothy Ulatowski, director of compliance for the agency's devices division.

___

On the Net:

Recent FDA warning letters: http://www.accessdata.fda.gov/scripts/wlcfm/recentfiles.cfm

Copyright 2007 AP Features
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright (c) Mochila, Inc.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Author:Staff
Publication:AP Features
Date:Jan 30, 2007
Words:271
Previous Article:Federal judge asks N.Y. Times reporter to appear in case of Zyprexa document disclosures
Next Article:Moody's: Cities' health care costs for retirees are rising faster than inflation



Related Articles
Victims of unapproved spinal operations fight back.
Medical devices implanted without patients' consent. (Food and Drug Administration report)
Offense or defense? Managing the off-label use claim.
FDA seeks antidepressant suicide warning
FDA warns obesity doctor over implants
FDA may expand antidepressant warning
Experts: Tell Public About Trauma Tests
Sterility worries lead to massive seizure of implantable medical devices
FDA asks antidepressant makers to warn young adults about suicide risks
Side effect reports triple after study ties diabetes drug to heart risks

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles